Search bioRxiv⌕ Search

Biology subjects

Borcard, L.

Publications and source records attributed to Borcard, L..

2 recordsLinked to original sources

PCR-free, targeted genomic sequencing using Dynamically optimized reference Adaptive Sampling (DORAS)

Whole genome sequencing (WGS) has become a cornerstone of clinical microbiology, enabling comprehensive analysis of microbial genome diversity. However, WGS is often computationally intensive and time-consuming when applied to specific applications like multilocus sequence typing (MLST), where only a subset of genes is only needed for typing. This study evaluates the potential of adaptive sampling (AS), a software-based solution available on Oxford Nanopore Technologies (ONT) devices, to optimize sequencing runs for MLST by reducing the production of unnecessary reads falling outside of the target areas. We demonstrate that AS, when used directly with the target gene sequences, does not reach sufficient target coverage when compared to WGS baseline sequencing due to inefficient read recruitment. Thus, we developed a novel, PCR-free approach, termed Dynamically Optimized Reference Adaptive Sampling (DORAS), which streamlines gene-specific enrichment by targeting genomic regions of interest and their genomic vicinity. DORAS first determines the genomic context of regions of interest for each sample, and then dynamically adjusts the length of the reference sequences during live sequencing. Consensus sequences are periodically constructed and evaluated for taxonomic classification. We demonstrate that full MLST profiles can be obtained in approximately half the time required for whole-genome sequencing to achieve 30X coverage (3 vs. 6 h), with no additional hands-on library preparation time. Validation on clinical isolates from hospital outbreaks belonging to Corynebacterium diphtheriae, vancomycin-resistant Enterococci, and routine clinical E. coli isolates, demonstrated the consistent retrieval of MLST types as compared to standard WGS methods. DORAS thus offers a cost-effective, efficient solution for routine surveillance and outbreak investigations based on MLST types in the clinical setting.

genomics↗

The developing T-cell compartment of the neonatal lung orchestrates an atypical response to respiratory syncytial virus

The human respiratory syncytial virus (RSV) is a major cause of severe lower respiratory tract infections in infants, possibly due to the specific features of the immature neonatal pulmonary immune system. Using the newborn lamb, a classical model of human lung development and a state-of-the-art model of RSV infection, we aimed to explore the role of cell-mediated immunity in RSV disease during early life. Remarkably, in healthy conditions, the developing T cell compartment of the neonatal lung showed major differences to that seen in the mature adult lung. The most striking observation being a high baseline frequency of bronchoalveolar IL-4-producing CD4 and CD8 T cells, which declined progressively over developmental age. RSV infection exacerbated this pro-type 2 environment in the bronchoalveolar space, rather than inducing a type 2 response per se. Moreover, regulatory T cell suppressive functions occurred very early to dampen this pro-type 2 environment, rather than shutting them down afterwards, while {gamma}{delta} T cells dropped and failed to produce IL-17. Importantly, RSV disease severity was related to the magnitude of those unconventional bronchoalveolar T cell responses. These findings provide novel insights in the mechanisms of RSV immunopathogenesis in early life, and constitute a major step for the understanding of RSV disease severity. AUTHOR SUMMARYBy using a state-of-the-art translational model with full accessibility to the small airways at defined early life periods, we provide an unpreceded characterization of the developing T cell compartment in the distal lungs of healthy and RSV-infected neonates. This process is highly dynamic and tightly regulated, characterized by colonizing T-cell subsets that synergize towards a narrow pro-tolerogenic immunological window. We believe our work constitutes a solid basis to clarify the age dependency of RSV immunopathogenesis, and should be considered in vaccine design, which remains challenging after five decades of effort.

immunology↗